Market LIVE
Published markets; coverage varies by country
Product profile · United States

BRINSUPRI

 ·  Patent Litigation & Settlement History ↓

IngredientBRENSOCATIB
Application typeNDA
Application217673
Product002
Dosage formTABLET
RouteORAL
Strength25MG
Approval date2025-08-12
Marketing statusPrescription
Status event—
ApplicantINSMED INC
Product source

Current GenericRadar decision

Year2035
SelectionDEEP_REVIEW
ReviewFINAL
Anchor typePATENT
Anchor date2035-03-12
Patent anchor2035-03-12
Exclusivity anchor2030-08-12
Protection date2040-02-21
First Final ANDA—
Status event—

GNR judgment: DEEP_REVIEW. Reference year: 2035. Anchor type: PATENT. Patent anchor: 2035-03-12. Exclusivity anchor: 2030-08-12. Anchor date: 2035-03-12. Patent tail: yes. Exclusivity tail: no. Review status: FINAL. Historical detailed rationale is retained in the evidence snapshot; this is a structured English summary, not a literal translation.

Patent estate

PatentEffective dateOfficial listingTRUE_DSDS gradeClaim classification / basisPTEPEDFamily
102872582035-01-21DS/U U-4257YNTRUE_DS
English description not available.
———
102872582035-01-21ORANGE_BOOK U-4257YNTRUE_DS
English description not available.
———
106692452035-01-21DS/U U-4257YNTRUE_DS
English description not available.
———
106692452035-01-21ORANGE_BOOK U-4257YNTRUE_DS
English description not available.
———
116552212035-01-21DP/U U-4257NNDP
English description not available.
———
116552212035-01-21ORANGE_BOOK U-4257NNDP
English description not available.
———
116552222035-01-21DS/U U-4257YNTRUE_DS
English description not available.
———
116552222035-01-21ORANGE_BOOK U-4257YNTRUE_DS
English description not available.
———
116552232035-01-21DS/U U-4257NNDP
English description not available.
———
116552232035-01-21ORANGE_BOOK U-4257NNDP
English description not available.
———
116552242035-01-21DP/U U-4257NNDP
English description not available.
———
116552242035-01-21ORANGE_BOOK U-4257NNDP
English description not available.
———
116738712035-01-21DP/U U-4257NNDP
English description not available.
———
116738712035-01-21ORANGE_BOOK U-4257NNDP
English description not available.
———
117730692035-01-21DP/U U-4257NNDP
English description not available.
———
117730692035-01-21ORANGE_BOOK U-4257NNDP
English description not available.
———
118143592035-01-21DS/U U-4257NNDP
English description not available.
———
118143592035-01-21ORANGE_BOOK U-4257NNDP
English description not available.
———
120544652035-01-21DS/U U-4257NNDP
English description not available.
———
120544652035-01-21ORANGE_BOOK U-4257NNDP
English description not available.
———
98158052035-01-21U U-4257NNU
English description not available.
———
98158052035-01-21ORANGE_BOOK U-4257NNU
English description not available.
———
95228942035-03-12DS —YNTRUE_DS
English description not available.
———
95228942035-03-12ORANGE_BOOK —YNTRUE_DS
English description not available.
———
122016382039-03-01DP —NNDP
English description not available.
———
122016382039-03-01ORANGE_BOOK —NNDP
English description not available.
———
120594242040-02-21DP —NNDP
English description not available.
———
120594242040-02-21ORANGE_BOOK —NNDP
English description not available.
———

Regulatory exclusivity

CodeStart dateEnd dateScopeEntire productAll indicationsFull coverage dateCombinationSource
NCE2025-08-122030-08-12English description not available.YY2030-08-12—Source
NCE2025-08-122030-08-12English description not available.YY2030-08-12
NCE
Full coverage date: 2030-08-12
Source

2026-10-10 · CURRENT_SOURCE_RECORDS_FOUND · Historical coverage: NOT_COMPLETE

Generic approval evidence

Application / productEventFinal dateTentative dateApplicantAuthorized genericExact mappingSource
No generic approval facts are linked to this product.

Market Entry Information

API filings, authorized generics and linked regulatory milestones.

API Master Files & Certifications 0 records

Ingredient-level registrations from linked public manufacturer portfolios. A filing does not establish supply to this finished product. DMFs are not FDA approvals.

APIHolder / manufacturerHolder countryFiling typeNumberStatusFiled dateAvailable for referenceSourceLast verified
No master-file or certification records are linked through public manufacturer portfolios.

Authorized Generics 0 records

Authorized generics are shown separately from independent ANDA approvals.

Application / productApplicantEvent / status First marketed Product mappingSourceLast verified
No authorized-generic records are linked to this product.

Tentative ANDA Approvals 0 records

Tentative approval is not final approval. Historical tentative approvals remain visible after a linked final approval.

Application / productApplicantEvent / status Tentative date Follow-up final approvalProduct mappingSourceLast verified
No tentative-approval records are linked to this product.

Paragraph IV Challenges 0 records

Paragraph IV challenges below are sourced from legal records separately from FDA approvals. An ANDA filing, lawsuit or settlement does not establish final approval or commercial launch.

Application / productApplicantEvent / status Certification event date Product mappingSourceLast verified
No structured Paragraph IV certification events are linked in the available approval evidence.

Final ANDA Approvals 0 records

Approval dates do not establish commercial launch. Product mapping is shown for each linked record.

Application / productApplicantEvent / status Final approval date Product mappingSourceLast verified
No final-approval records are linked to this product.
Decision evidence (16)
TypeDateRoleBasisSource
PATENT2035-01-21HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2035-01-21HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2035-01-21HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2035-01-21HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2035-01-21HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2035-01-21HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2035-01-21HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2035-01-21HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2035-01-21HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2035-01-21HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2035-01-21HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2035-03-12CANONICAL_ANCHOREnglish description not available.Source
PATENT2039-03-01FTO_TAILEnglish description not available.Source
PATENT2040-02-21FTO_TAILEnglish description not available.Source
REGULATORY_EXCLUSIVITY—REGULATORY_SCOPE_CONTEXTEnglish description not available.Source
REGULATORY_STATUS2035-03-12CANONICAL_DECISIONEnglish description not available.Source
Independent legal-event information

Litigation & Settlement History

Settlement launch rights generally apply only to the named parties and product scope. These records do not change GenericRadar patent/exclusivity anchors or current decisions.

No litigation or settlement record currently linked to this product.